Press Releases WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Market Closed - OTC Markets Other stock markets 20:25:05 07/06/2024 BST			5-day change	1st Jan Change
2.813 ^USD	-3.48%		-0.95%	-62.24%

06-01	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE
05-31	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

WuXi Biologics Enhances Manufacturing Capability with the Installation of Three 5,000L Single-Use Bioreactors	06-06	AQ
WuXi facility boosts bioprocessing capacity with new bioreactors	06-06	AQ
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment	04-30	PU
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024	04-16	AQ
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories	04-03	AQ
WuXi Biologics Reports Solid 2023 Annual Results	03-27	AQ
WuXi Biologics Named to CDP 'A List' for Water Security	03-25	AQ
WuXi Biologics Cayman : Breaks Ground on CRDMO Center in Singapore	03-19	PU
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment	03-06	AQ
WuXi Biologics Ireland Site Receives Three ISO Certifications	03-04	AQ
WuXi Biologics achieves large-scale manufacturing milestone	01-31	AQ
WuXi Biologics Launches WuXiaADCC PLUSTM for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect	01-26	AQ
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBodyTM	01-18	AQ
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates	01-12	AQ
WUXI BIOLOGICS TO PARTICIAPTE AT 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	01-10	AQ
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts	01-09	AQ
WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating	12-11	AQ
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of 6 g/L/day at Pilot Scale	11-23	AQ
Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics	11-21	AQ
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange	11-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Press Releases

Filters